Healthy Adult Reference Biobank for Cardiovascular Biomarkers in China (NCT07136675) | Clinical Trial Compass
By InvitationNot Applicable
Healthy Adult Reference Biobank for Cardiovascular Biomarkers in China
China2,400 participantsStarted 2025-04-22
Plain-language summary
Establishing reference intervals for high-sensitivity cardiac troponin in the apparently healthy population in China.
Who can participate
Age range20 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
Apparent healthy Chinese individuals, aged between 20 and 80 years; Normal electrocardiogram (ECG) during physical examination; Signed informed consent form.
Exclusion criteria:
Musculoskeletal disease or a history of rheumatoid arthritis, or high-intensity exercise (e.g., marathon) within the past week; Biotin treatment within the past week; Hospitalization for an emergency within the past three months; Pregnancy or lactation within the past year; Diabetes: fasting blood glucose ≥ 7.0 mmol/L; glycated hemoglobin (HbA1c) ≥ 6.5%; Chronic kidney disease: estimated glomerular filtration rate (eGFR) \< 60 mL/min/1.73 m²; Latent heart disease: NT-proBNP \> 125 ng/L or BNP \> 35 ng/L; Known cardiovascular or heart disease in the past: treated with medication or other interventions; Chronic diseases that may affect the heart (cancer/tumor, autoimmune diseases); Hemolysis, lipemia, or insufficient residual sample volume for testing.
What they're measuring
1
Detection of high-sensitivity troponin
Timeframe: On the day of the physical examination
Trial details
NCT IDNCT07136675
SponsorChina National Center for Cardiovascular Diseases